Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Precision Medicine market 2020 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

  • Purchase Options

 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Overview

Precision medicine sometimes referred to as "holistic medicine" is a highly specialized way to tailor personalized medicine to specific individuals, taking into consideration differences in genetics, histories, and environments. The aim of precision medicine is to only target the appropriate treatments to the appropriate patients at the appropriate time with the best possible outcomes. It is used to make medical interventions more efficient and less harmful to patients. The global precision medicine market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global precision medicine market is expected to witness significant growth during the forecast period, owing to technological advancements in cancer biology.

Market Drivers

Increasing collaborative efforts among key companies are expected to drive growth of the global precision medicine market during the forecast period. Personalized medicine is manufactured specifically for unique individuals based on their predicted response or risk of disease.  The demand for personalized medicine has increased in the recent past as physicians can provide more effective drugs and avoid potential side effects. For instance, in May 2021, AdventHealth partnered with Sema4 to launch a precision medicine program. Hence, such factors are expected to drive growth of the global precision medicine market during the forecast period. Furthermore, technological advancements in cancer biology are expected to propel the global precision medicine market growth over the forecast period.

Market Restraint

High cost associated with precision medicines and stringent regulatory policies is expected to restrain growth of the global precision medicine market during the forecast period.

Regional Insights

Among regions, North America is expected to witness significant growth in the global precision medicine market during the forecast period. This is owing to the presence of robust healthcare infrastructure and high investment in R&D activities across the region. Furthermore, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to rising disposable income and improving healthcare infrastructure in the region.

Competitive Section

Major companies involved in the global precision medicine market are Novartis AG, Intomics, Ferrer Incode, Nanostring Technologies, Inc., Pfizer, Inc., Teva Pharmaceuticals, Merck & Co., Inc., Qiagen N.V., and Quest Diagnostics.

Recently, in February 2019, QIAGEN N.V. received the CE marking for its therascreen PIK3CA RGQ PCR Kit in Europe to enhance precision medicine in advanced breast cancer. 

Market Taxonomy

This report segments the global precision medicine market on the basis of technology and application. On the basis of technology, the global precision medicine market is segmented into bioinformatics, gene sequencing, drug discovery, precision molecular diagnostics, and big data analytics. Applications of precision medicine include oncology, CNS, hematology, respiratory, and immunology, among others.

Key features of the study:

  • This report provides an in-depth analysis of precision medicine in medical sector and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2016 - 2024), considering 2015 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, product pipeline, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global precision medicine market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Novartis AG, Intomics, Ferrer Incode, Nanostring Technologies, Inc., Pfizer, Inc., Teva Pharmaceuticals, Merck & Co., Inc., Qiagen N.V., and Quest Diagnostics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics
  • The global precision medicine market report caters to various stakeholders in this industry including investors, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the precision medicine market

Detailed Segmentation:

• Global Precision Medicine Market, By Technology:
o Bioinformatics
o Gene Sequencing
o Drug Discovery
o Precision Molecular Diagnostics
o Big Data Analytics

• Global Precision Medicine Market, By Application:
o Oncology
 Breast cancers
 Lung Cancer
 Others
o CNS
o Hematology
o Respiratory
o Immunology
o Others

• Global Precision Medicine Market, By Geography:
o North America
 U.S.
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Canada
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
o Europe
 U.K.
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Germany
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Italy
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 France
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Russia
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Rest of Europe
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
o Asia Pacific
 China
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 India
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Japan
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 ASEAN
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Australia
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 South Korea
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Rest of Asia Pacific
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
o Latin America
 Brazil
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Mexico
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Rest of Latin America
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
o Middle East
 GCC
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Israel
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
o Africa
 North Africa
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 Central Africa
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others
 South Africa
 By Technology:
 Bioinformatics
 Gene Sequencing
 Drug Discovery
 Precision Molecular Diagnostics
 Big Data Analytics
 By Application:
 Oncology
 Breast cancers
 Lung Cancer
 Others
 CNS
 Hematology
 Respiratory
 Immunology
 Others

• Company Profiles

o Intomics.*
 Company Overview
 Product Portfolio
 Financial Performance
 Key Strategies
 Recent Developments
 Future Plans
o Ferrer Incode
o Nanostring Technologies, Inc.
o Tepnel Pharma Services
o Pfizer, Inc.
o Novartis AG
o Teva Pharmaceuticals
o Merck & Co., Inc.
o Qiagen N.V.
o Quest Diagnostics
"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet By Technology
? Market Snippet By Application
? Market Snippet By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o PEST Analysis
o Market Trends
o Value Chain
4. Global Precision Medicine Market, By Technology, 2017 and 2025 (USD Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2017 and 2025
? Segment Trends
o Bioinformatics
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Gene Sequencing
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Drug Discovery
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Precision Molecular Diagnostics
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Big Data Analytics
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
5. Global Precision Medicine Market, By Application, 2017 and 2025 (USD Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2017 and 2025
? Segment Trends
o Oncology
? Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2017 and 2025
? Breast Cancer
? Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2017 and 2025
? Lung Cancer
? Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2017 and 2025
? Others
? Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, 2017 and 2025
o CNS
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Hematology
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Respiratory
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Immunology
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
o Others
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2017 and 2025, (USD Million)
6. Global Precision Medicine Market, By Regions, 2017 and 2025 (USD Million)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, For Regions, 2017 and 2025
o North America
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2017 and 2025
? U.S.
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Canada
? Market Size and Forecast, 2017 and 2025 (USD Million)
o Europe
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2017 and 2025
? U.K.
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Germany
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Italy
? Market Size and Forecast, 2017 and 2025 (USD Million)
? France
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Russia
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Others
? Market Size and Forecast, 2017 and 2025 (USD Million)
o Asia Pacific
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2017 and 2025
? China
? Market Size and Forecast, 2017 and 2025 (USD Million)
? India
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Japan
? Market Size and Forecast, 2017 and 2025 (USD Million)
? ASEAN
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Australia
? Market Size and Forecast, 2017 and 2025 (USD Million)
? South Korea
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Others
? Market Size and Forecast, 2017 and 2025 (USD Million)
o Latin America
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2017 and 2025
? Brazil
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Mexico
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Others
? Market Size and Forecast, 2017 and 2025 (USD Million)
o Africa
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2017 and 2025
? Northern Africa
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Central Africa
? Market Size and Forecast, 2017 and 2025 (USD Million)
? South Africa
? Market Size and Forecast, 2017 and 2025 (USD Million)
o Middle East
? Market Share Analysis, By Country, 2016 and 2025 (%)
? Y-O-Y Growth Analysis, By Country, 2017 and 2025
? GCC Countries
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Israel
? Market Size and Forecast, 2017 and 2025 (USD Million)
? Rest of Middle East
? Market Size and Forecast, 2017 and 2025 (USD Million)
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Intomics
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Ferrer Incode
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Nanostring Technologies, Inc.
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Tepnel Pharma Services
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Pfizer, Inc.
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Novartis AG
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Teva Pharmaceuticals
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Merck & Co., Inc.
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Qiagen N.V.
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Quest Diagnostics
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
8. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 23 market data tables and 29 figures on "Precision Medicine Market - Global forecast to 2025".

 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us